reference/27782994

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27782994

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1771
issn	0007-1188 1476-5381
issueIdentifier	8
pageRange	1756-1771
publicationName	British Journal of Pharmacology
startingPage	1756
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e08b897aed34c336460d8467f724fbdb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7d00ef309615caf1ece180111444bb97 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d74d8b58080c8e4d52ac61a54e829bfe http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d2827f0b732138eca74c4ae464547899 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f091531ef24b90b59e66c488624e8d2e
bibliographicCitation	Yang X, Liu Q, Li Y, Ding Y, Zhao Y, Tang Q, Wu T, Chen L, Pu S, Cheng S, Zhang J, Zhang Z, Huang Y, Li R, Zhao Y, Zou M, Shi X, Jiang W, Wang R, He J. Inhibition of the sodium-glucose co-transporter SGLT2 by canagliflozin ameliorates diet-induced obesity by increasing intra-adipose sympathetic innervation. Br J Pharmacol. 2021 Apr;178(8):1756–71. doi: 10.1111/bph.15381. PMID: 33480065.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c827c9e6eca69c0527f83882caca2f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15552c9620a437059ac5c8cce700ed36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b539f0d1a13f06bc80065d10768e8876 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3b3702f1eda353bc5b6945f0d091923 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_349183f1f1c9059537757ad5c488bf99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3022570f0bed0a8a7970fef8f8bf725 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd2107580ddb560a64433036162df39e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c178cfd1cd088a33da21de778e8ab3b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01433bf810fba03bbec317e3f0fc1c39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1939e48b0bd5c24d6c4b41f8c614d970 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e63e96b2e558d185f708a3c97e997377 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ad3557236a6d2192e2c0e980364ac69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_780fde1751691e39dd00e02b8f7e993a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e114138d8e14f30f4a623c851a28cf4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eef5852e8d1bc591dbf8c860b9396932 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff1ef794dc5be67e9c86958a4de78284 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6487-4696 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_170d793c80bbf0aed5cd9162b3141362 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_043a6f7772a36095e82993c62701b1dc
date	202103
identifier	https://pubmed.ncbi.nlm.nih.gov/33480065 https://doi.org/10.1111/bph.15381
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1895 https://portal.issn.org/resource/ISSN/0007-1188 https://portal.issn.org/resource/ISSN/1476-5381
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Inhibition of the sodium–glucose co‐transporter SGLT2 by canagliflozin ameliorates diet‐induced obesity by increasing intra‐adipose sympathetic innervation
discusses	http://id.nlm.nih.gov/mesh/M0480065 http://id.nlm.nih.gov/mesh/M0550188 http://id.nlm.nih.gov/mesh/M0020091 http://id.nlm.nih.gov/mesh/M0009339
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000068896 http://id.nlm.nih.gov/mesh/D000072078
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012964 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D059305Q000009 http://id.nlm.nih.gov/mesh/D005947 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D051297 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000273 http://id.nlm.nih.gov/mesh/D009765Q000209 http://id.nlm.nih.gov/mesh/D009765Q000188
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a95245167042cebb599d71e1a81bf6d4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8179 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d8aac23862060e4b5b27ff5382ec1109 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7708 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24812758

Total number of triples: 74.